CN104130984B - Act on the aflatoxin oxidase of versicolorin - Google Patents

Act on the aflatoxin oxidase of versicolorin Download PDF

Info

Publication number
CN104130984B
CN104130984B CN201410370164.3A CN201410370164A CN104130984B CN 104130984 B CN104130984 B CN 104130984B CN 201410370164 A CN201410370164 A CN 201410370164A CN 104130984 B CN104130984 B CN 104130984B
Authority
CN
China
Prior art keywords
versicolorin
aflatoxin
oxidase
afo
ver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410370164.3A
Other languages
Chinese (zh)
Other versions
CN104130984A (en
Inventor
刘大岭
蒋海兰
姚冬生
谢春芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Fang can animal health care Co.,Ltd.
Original Assignee
Jinan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinan University filed Critical Jinan University
Priority to CN201410370164.3A priority Critical patent/CN104130984B/en
Publication of CN104130984A publication Critical patent/CN104130984A/en
Application granted granted Critical
Publication of CN104130984B publication Critical patent/CN104130984B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a kind of aflatoxin oxidase acting on versicolorin.The critical amino acid residues of wild type aflatoxin oxidase (AFO) substrate-binding site is transformed by the present invention by technique for gene engineering, it is provided that a kind of AFO mutant obtaining the selectivity to substrate versicolorin (Ver A) and affinity raising.The mutant aflatoxin oxidase (mAFO acting on versicolorin of the present invention555), the selectivity ratios wild type AFO of substrate Ver A is improved 18 times, the affinity of substrate Ver A is improved 6 times than wild type AFO;Raising 4 times to the specific enzyme activity force rate wild type AFO of Ver A.

Description

Act on the aflatoxin oxidase of versicolorin
Technical field
The present invention relates to aflatoxin oxidase, be related specifically to act on the aflatoxin oxidase of versicolorin.
Background technology
Aflatoxin oxidase (Aflatoxin oxidase, AFO) it is the one endocellular enzyme that derives from Armillariella tabescens (Armillariella tabescens), have the advantages that can directly convert family's aflatoxin in vitro, research shows: it is a redox reaction that AFO converts the process of AFB1 (AFB1), is attended by H2O2Generation, it acts on the toxophore bifuran of AFB1, causes the furan double bond in bifuran to rupture, thus changes into non-toxic products.
Versicolorin (Ver A) is the front extract in AFB1 biosynthetic process, its molecular structure there is also the bifuran identical with AFB1, the enzyme electrode utilizing AFO (wild type) to make carries out the research of electrochemical Characterization and finds that wild-type enzyme electrode has response signal to Ver A Ver A, but sensitivity is low, signal is inconspicuous.This explanation: although wild type aflatoxin oxidase there is also transformation to VerA, but act on insensitive.
Versicolorin (VerA, versicolorin A) i.e. 1,6,8-trihydroxy-2-methylol anthraquinone, it is AFB1 and sterigmatocystin (sterigmytocystin, ST) the important as precursors thing in anabolic process, its structure contains the toxophore bifuran identical with AFB1 and ST.Research shows to be monitored grain VerA in storage, it is possible to not yet detection or the only agricultural product such as low-level the detection grain of aflatoxin, feedstuff are played the forewarning function of pollution.I.e. under original state, the positive detection of the VerA of certain level (even if AFB1 not yet detects or only low-level detection), it is possible to pollution level and the pollution risk of the aflatoxin of these agricultural product after certain time is deposited in prompting under certain condition.The described mutant enzyme of the present invention sensitive can produce oxidation reaction to VerA rapidly, is assembled on electrode, then can obtain the biological sensor electrode sensitive to VerA response.In addition, the eighties in 20th century, the acute toxicity of the preliminary study such as Wong VerA and teratogenesis degeneration, its LD50 (mouse mainline) is 20mg/kg, mutagenesis dosage (Ames test) is 800ng/ ware, thus the toxicity of versicolorin itself can not be ignored.
Before producing AFB1, the cumulative process of a Ver A is there will be owing to producing poison mycete, although wild type AFO has a certain degree of decomposition to Ver A, but the AFO mutant in the present invention is to the effect of VerA is sensitiveer and conversion ratio is higher, can terminate and disturb product poison mycete synthesis AFB1 in theory, thus reach the purpose blocked or retardation AFB1 is formed.
Summary of the invention
The primary and foremost purpose of the present invention is to provide a kind of aflatoxin oxidase acting on versicolorin.
The present invention is that the oxidasic gene of the aflatoxin to Armillariella tabescens (referred to as AFO gene) carries out rite-directed mutagenesis.By the aflatoxin oxidase obtained in Armillariella tabescens (Armillariella tabescens) AS165, it is sequenced (A fungal enzyme with the ability of aflatoxin B1conversion:Purification and ESI-MS/MS identification, Microbiological Research 166 (2011) 475 483), GENBANK accession number is AY941095.The aminoacid sequence of this oxidasic maturation protein is SEQ ID NO.1.
According to a kind of Fixedpoint mutation modified aflatoxin oxidase of the present invention, be by aminoacid sequence be SEQ ID NO.1 the aflatoxin oxidase deriving from Armillariella tabescens (Armillariella tabescens) in manufacture multiple aminoacid replacement and produce, the oxidase higher to versicolorin specificity, described aminoacid replacement is the replacement of the 404th, 410,493,497 and 501.
According to the oxidasic further feature of Fixedpoint mutation modified aflatoxin of the present invention, the described aminoacid replacement at the 404th is to replace valine with lysine;It is to use cysteine substituted lactamine at the aminoacid replacement of 410;It is to replace glutamic acid with tryptophan at the aminoacid replacement of the 493rd;It is to replace glutamic acid with tyrosine at the aminoacid replacement of the 497th;It is to replace glutamic acid with methionine at the aminoacid replacement of the 501st;The described Fixedpoint mutation modified oxidasic aminoacid sequence of aflatoxin is SEQ ID NO.2.
Mutant aflatoxin oxidase (mAFO) acting on versicolorin of the present invention, the selectivity ratios wild type AFO of substrate Ver A is improved 18 times, than wild type AFO, the affinity of substrate Ver A is improved 6 times by it.Raising 4 times to the specific enzyme activity force rate wild type AFO of Ver A.
Further, the invention provides a kind of DNA molecular, it encodes the aflatoxin oxidase acting on versicolorin of the present invention.
Preferably, the nucleotides sequence of DNA molecular of the present invention is classified as SEQ ID NO.3.
It is a further object to provide a kind of carrier, it contains DNA molecular of the present invention.
A further object of the present invention is to provide a kind of host cell, and it contains DNA molecular of the present invention, or containing carrier of the present invention.
Above-mentioned carrier and host cell can be prepared by technological means well known in the art.
Present invention also offers the oxidasic production method of aflatoxin acting on versicolorin of the present invention, including: under conditions of being suitable to aflatoxin Oxidase Expression, cultivate host cell of the present invention, and from culture medium, separate described aflatoxin oxidase.
When DNA molecular of the present invention is inserted into described carrier with suitably orientation and correct reading frame, or proceeding in described host cell, described DNA molecular can be expressed in any eucaryon or prokaryotic expression system.Many host-vector systems may serve to marking protein coded sequence.Host-vector system includes but not limited to: the antibacterial converted with phage, plasmid or cosmid;Containing the microorganism of yeast vector, such as yeast;The mammalian cell system infected by virus;The insect cell system infected by virus;The plant cell system infected with antibacterial.Currently preferred carrier includes viral vector, plasmid, cosmid or oligonucleotide.
Currently preferred host is prokaryotic system such as bacillus subtilis, it is also possible to eukaryotic expression system such as Pichia sp.;Preferred expression is escherichia coli, such as Rosetta (DE3);Purification tag MBP also can be selected for other purification tag, such as 6 histidine.
Currently preferred protein expression method is lactose-induced expression;The solubility expression of more preferably IPTG induction.
Currently preferred method of purifying protein is can be with conventional protein chromatography technology, and such as ion-exchange chromatography and hydrophobic chromatography are combined;Preferred purification process is affinity chromatograph, such as Amylose affinity chromatograph.
Further, present invention also offers a kind of biosensor, it contains the aflatoxin oxidase acting on versicolorin of the present invention.
Invention further provides the purposes of described biosensor, i.e. for detecting the purposes of the content of the versicolorin in grain, food and raw material thereof, feedstuff.
Accompanying drawing explanation
Fig. 1 shows mAFO555Selectivity (K to Ver AAFB1m/KVerAM value).
Detailed description of the invention
Term employed in Ben Wen, except as otherwise noted, is the implication that those skilled in the art are generally understood that.The definition of some specific teries used in the present invention presented below.
" AFO " represents wild type Aflatoxin-detofizyme ADTZ, and its gene represents with italic AFO.
" mAFO " represents mutant Aflatoxin-detofizyme ADTZ, and its gene represents with mAFO.
“mAFO555" representing No. 555 mutant Aflatoxin-detofizyme ADTZs, its gene is with mAFO555Represent.
Embodiment 1: the PCR amplification of Aflatoxin-detofizyme ADTZ gene and order-checking
1, the present invention using armillariella tabescens originate Aflatoxin-detofizyme ADTZ gene (AY941095.1) sequence as reference, software Primer 5 is used to design and synthesize two oligonucleotide primers, PBA plasmid in alkaline lysis method of extracting DH-5a, by PCR method amplifying target genes AFO.
Article two, PCR primer is as follows:
Forward primer: 5 ' ATGGCCACCACAACTGTCCACCGG 3 '
Reverse primer: 5 ' CGCGGATCCTCACAATCGTCTCTCAATGAAAC 3’
Dashed part is BamH I restriction enzyme site.
PCR reaction system is as follows:
PBA (template) 1.6ul
Forward primer 1.2ul
Reverse primer 1.2ul
10xKOD buffer 4ul
KOD-Plus-NEO 0.8ul
DNTP 4ul
ddH2O 24.8ul
PCR program setting:
94 DEG C of denaturations 5min;
94 DEG C, 40s;55 DEG C, 40s;68 DEG C, 65S 5 circulation;
94 DEG C, 40s;62 DEG C, 40s;68 DEG C, 65S 25 circulation;
68 DEG C, 5min.
Pcr amplification product, after the agarose gel electrophoresis of 1%, reclaims test kit with DNA and carries out glue recovery, obtain the fragment of about 2.1kb.
Embodiment 2: Aflatoxin-detofizyme ADTZ gene (AFO) and the connection of expression vector pMAL-C2X
1. expression vector pMAL-C2X carries out restricted enzyme BamH I, PdmI double digestion, and mAFO genes of interest carries out restricted enzyme BamH I single endonuclease digestion, and in 37 DEG C of enzyme action 10min, enzyme action condition is as follows:
2. digestion products is separately recovered two purpose fragments after the agarose gel electrophoresis of 1%, connects with T4DNA ligase, and linked system is as follows:
AFO digestion products 13ul
PMAL-C2X digestion products 4ul
T4DNA enzyme 0.2ul
10 × buffer 2ul
ddH2O 0.8ul
Total amount 20ul
3h is connected with ligase 22 DEG C, connect after product converts the amplification of Rosetta (DE3) competent cell and extract plasmid with plasmid extraction test kit, 6.6kb and 2.1kb two band is shown with running electrophoresis result after SacI/BamHII double digestion, show successful connection, by DNA sequencing, it is defined as Aflatoxin-detofizyme ADTZ gene.
Embodiment 3: rite-directed mutagenesis
1, through utilizing DS3.0 software platform that the simulation three dimensional structure of aflatoxin toxin detoxication enzyme is carried out bioinformatic analysis, we determined that the aminoacid to following site carries out Fixedpoint mutation modified:
(1) for the amino acid mutation of the 404th amino acids, design primer is as follows:
mAFOV404K
Forward mutation primer:
5’ATTTTGGCGGCCAAGAAGCCAAACGAGGAGTTAAC 3’SEQ ID NO.6
Inverse transition primer:
5’GTTAACTCCTCGTTTGGCTTCTTGGCCGCCAAAAT 3’SEQ ID NO.7
(2) for the 410th amino acids sudden change, design primer is as follows:
mAFOV404K/T410C
Forward mutation primer:
5’CAAACGAGGAGTTATGCTTCATCCATCCTGATG 3’SEQ ID NO.8
Inverse transition primer:
5’CATCAGGATGGATGAAGCATAACTCCTCGTTTG 3’SEQ ID NO.9
(3) suddenling change for the 497th and 501 amino acids, design primer is as follows:
mAFOV404K/T410C/E497Y/L501M
Forward mutation primer:
5’GAATGCTGGGCGTACACCGTAGCGATGTACTTGGTTAGC 3’SEQ ID NO.10
Inverse transition primer:
5’GCTAACCAAGTACATCGCTACGGTGTACGCCCAGCATTC 3’SEQ ID NO.11
(4) for 493 amino acids sudden changes, design primer is as follows:
mAFOV404K/T410C/E493W/E497Y/L501M
Forward mutation primer: 5 ' GTCGTCAATGGAATGGTGTCGGGCGTAC 3 ' SEQ ID NO.12
Inverse transition primer: 3 ' GTACGCCCGACACCATTCCATTGACGAC 3 ' SEQ ID NO.13
PCR program setting:
94 DEG C of denaturations 2min;
94 DEG C, 30s;63 DEG C, 30s;68 DEG C, 65S 5 circulation;
94 DEG C, 30s;59 DEG C, 30s;68 DEG C, 65S 25 circulation;
68 DEG C, 5min.
Order-checking is connected after PCR reaction.Site-directed point mutation is the method using Overlap extension PCR, suddenlys change five sites successively, and the DNA sequence finally given can be expressed as the present invention and acts on the aflatoxin oxidase of versicolorin, and this enzyme is referred to as " mAFO555”。
Embodiment 4:Rosetta (DE3)-pMAL-C2X-mAFO555Solubility induction and MBP-mAFO555The expression of fusion protein
By Rosetta (DE3)-pMAL-C2X-mAFO solubility abduction delivering condition is come fusion protein MBP-mAFO555Carry out abduction delivering.Purification tag MBP i.e. maltose-binding protein (Maltose-binding protein).Protein table is carried out as promoter with lac operon, and the most excellent with isopropylthio β-D-galactoside (Isopropylthio-β-D-galactoside, IPTG), and the latter can add and carry out successive induction expression in the medium.
(1) 10 μ LRosetta (DE3)-pMAL-C2X-mAFO are drawn555Glycerol preserve bacterium solution in 990 μ L LB fluid mediums, the most hand mixing, be then diluted to 10 with LB fluid medium4、105、106、107、108Six Concentraton gradient;
(2) 100 μ L/ plates 10 are drawn5、106、107、108The bacterium solution of five concentration is coated in the LB solid medium containing ampicillin (100 μ g/mL), is inverted overnight incubation in 37 DEG C after drying at room temperature;
(3) the preferably single bacterium colony of growing way on toothpick picking flat board, is placed in the LB fluid medium containing ampicillin (100 μ g/mL), and 37 DEG C of 150rpm/min overnight shakings are cultivated;
(4) overnight culture is seeded to containing ampicillin (100 μ g/mL) and the rich medium of glucose (0.2%) by 1:100, and 37 DEG C of 150rpm/min cultivations are 0.4~0.8 to OD600;
(5) add IPTG and carry out abduction delivering 60 hours to final concentration of 0.24mM, 20 DEG C of 150rpm/min.
(6) 2000~1000g, 4 DEG C are centrifuged, and gather in the crops thalline, and freezen protective.
Embodiment 5: fusion protein MBP-mAFO555" isolation and purification
(1) fermentation culture medium thawed at room temperature, adds 25mL Column buffer mixing, and the thalline re-suspension liquid after thawing is taken out 25mL and is placed in ice-water bath;
(2) arranging ultrasonication parameter is: intermittently 10 seconds, ultrasonic 5 seconds, power 800W.Ice-bath ultrasonic is broken until bacteria suspension becomes clear;
At (3) 4 DEG C 9,000g is centrifuged 20 minutes, take supernatant be stored in 4 DEG C standby;
(4) by 15mL Amylose Filled Dielectrics in the pillar that specification is 1.0 × 20cm.Ultra-pure water Peak Flow Rate compression leg 2h.Connect nucleic acid-protein detector, with Column buffer balance pillar to baseline stability.
(5) loading volume: every mL bed volume can be in conjunction with 3mg fused protein.
(6) by breaking cellular wall supernatant peristaltic pump with the flow velocity loading of 0.2mL/min, after end of the sample, use Column Buffer with same uniform flow eluting;
(7) observing the ultraviolet absorption value at nucleic acid-protein detector 280nm when loading starts, collect eluent when absorption value starts to raise, be eluted to during baseline stop receiving, the solution herein collected is the drip washing peak of affinity chromatograph;
(8) with Column Buffer+10mM maltose eluting fused protein.At nucleic acid-protein detector 280nm, absorption value collects eluent when starting to raise, and is eluted to during baseline stop receiving, and the solution herein collected is MBP-mAFO555
(9) with reference to pMAL system specification (reagent handbook), 4 DEG C, the MBP-mAFO that affinity chromatograph obtains555Fusion protein was with Factor Xa enzyme action 36 hours.
The removal of embodiment 6:MBP label and destination protein mAFO555Acquisition
After protein product is carried out corresponding affinity chromatograph and enzyme action, again carry out affinity chromatograph and be achieved with the destination protein of purification.
(1) by 15mL Amylose Filled Dielectrics in the pillar that specification is 1.0 × 20cm.Ultra-pure water Peak Flow Rate compression leg 2h.Connect nucleic acid-protein detector, with Column buffer balance pillar to baseline stability.
(2) loading volume: every mL bed volume can be in conjunction with 3mg fused protein.
(3) will be containing MBP label and mAFO555Mixed solution and column-loading buffer Column Buffer mix in the ratio of 1:5, with peristaltic pump with the flow velocity loading of 0.2mL/min;
(4) use Column Buffer with same uniform flow eluting after end of the sample, the ultraviolet absorption value at nucleic acid-protein detector 280nm is observed when loading starts, collecting eluent when absorption value starts to raise, be eluted to during baseline stop receiving, the solution herein collected is containing mAFO555Component.
Embodiment 7: purpose mAFO555Character measure
1, the oxidasic property testing of aflatoxin of versicolorin is acted on:
1. mAFO is measured by the Auto-iTC200 micro-calorimeter of type isothermal titration555/ the wtAFO affinity to AFB1/Ver A.Method is as follows:
Use single titration method, using Ver A/AFB1 solution as volumetric solution, mAFO555/ wtAFO solution is as titrate, and single titration volumes is 25uL, and the persistent period is 50s, and interval time is 2000s, and feedback model is High, and temperature is 30 DEG C, and mixing speed is 700r/min.Using the deionized water in reference cell as the thermally equilibrated reference of sample cell.Separately do a blank experiment to eliminate the impact of the heat of dilution between solution simultaneously, i.e. replace sample with buffer, titrate with Ver A/AFB1 solution.During each sample titration, the sample treatment of experimental group is as shown in table 1, only substitutes sample liquid with buffer (pH7.4,20mM Tris-HCl) in matched group.
Table 1: sample treatment, unit (ul)
(m) AFO drawn from measurement result is respectively with Ver A and AFB1As kinetic constant during catalytic substrate, it is shown in Table 2.The affinity of enzyme is represented with 1/Km.
As shown in table 2, compared with wild type AFO, mAFO555The affinity (1/Km) of substrate Ver A is improve 7.53 times, and the affinity of substrate A FB1 is reduced 0.56 times.
Table 2:mAFO555Kinetic constant
MAFO is to Ver A and AFB1Selectivity as shown in Figure 1.By (1/KmVerA)/(1/KmAFB1) (i.e. KmAFB1/KmVerA) mAFO can be evaluated555Selectivity between substrate Ver A and AFB1.This value shows the most greatly mAFO555The highest to the selectivity of Ver A, this value is the least, shows mAFO555To AFB1Selectivity the highest.Result shows: mAFO555It is 19.4 times of wild type AFO to the selectivity of substrate Ver A.
2, enzyme activity determination:
With VerA as substrate, measure the amount (as shown in Equation 1) of the hydrogen peroxide that this substrate of enzyme catalysis produces.HRP in formula: horseradish peroxidase;RBG: negative viride nitens;BG: viride nitens.Under conditions of HRP exists, the hydrogen peroxide (H produced in course of reaction2O2) the most, the amount that RBG changes into BG is the most.Measure at 630nm.
The definition of enzyme activity unit a: unit (U) is defined as at 30 DEG C, under conditions of pH is 5.8, per minute by Ver A convert release 1pmol H2O2 required for enzyme amount.M () AFO enzyme activity is calculated by following formula 2:
In formula 2:
XDThe AFO enzyme activity of sample diluent, unit: U/ml;
The slope of a standard curve;
A0The absorption value of sample blank group;
The absorption value of A specimen reaction group;
The intercept of b standard curve;
2 reaction volumes, unit: ml;
109Conversion factor, 1mmol=109pmol;
1000 conversion factors, 1ml=1000 μ l;
30 response time, for 30min;
It is 100 μ l that 100 sample diluents add volume.
Measurement result is as shown in table 3.
The Rate activity (substrate Ver A) of table 3. enzyme
Enzyme Wild type AFO (U/mg) mAFO555(U/mg)
The ratio of enzyme is lived (2.3±0.3)×103 (9.5±0.5)×103
2. mAFO is measured by the Auto-iTC200 micro-calorimeter of type isothermal titration555/ the wtAFO selectivity to AFB1/Ver A.Method is as follows:
Utilize iTC technical measurement mAFO555Km value in the Ver solution A containing variable concentrations AFB1, titrate mAFO in titration process555Concentration be 10nM, the concentration of volumetric solution Ver A is 10 μMs, and the concentration of AFB1 is respectively 1/2,1/4,1/5,1/6,1/7,1/8,1/10,1/20,1/40,1/50,1/80, the 1/100 of Ver A concentration.In titration experiments, using single titration method, titration volumes is 25uL, and the persistent period is 50s, and interval time is 2000s, and feedback model is " High ", and temperature is 30 DEG C, and mixing speed is 700r/min.Using the deionized water in reference cell as the thermally equilibrated reference of sample cell.

Claims (8)

1. the aflatoxin oxidase acting on versicolorin, it is characterised in that: it is to be SEQ by aminoacid sequence The aflatoxin oxidase deriving from Armillariella tabescens (Armillariella tabescens) of ID NO.1 manufacture multiple Aminoacid replacement and produce, the oxidase higher to versicolorin specificity;Produced by act on versicolorin The oxidasic aminoacid sequence of aflatoxin is SEQ ID NO.2.
2. a DNA molecular, it is characterised in that: the Aspergillus flavus poison acting on versicolorin described in its coding claim 1 Element oxidase.
DNA molecular the most according to claim 2, it is characterised in that: its nucleotides sequence is classified as SEQ ID NO.3.
4. a carrier, it is characterised in that: it contains the DNA molecular described in Claims 2 or 3.
5. a host cell, it is characterised in that: it contains the DNA molecular described in Claims 2 or 3, or wants containing having the right Seek the carrier described in 4.
6. the oxidasic production method of aflatoxin acting on versicolorin according to claim 1, its Being characterised by, described method includes: cultivate the place described in claim 5 under conditions of being suitable to aflatoxin Oxidase Expression Chief cell, and from culture medium, separate described aflatoxin oxidase.
7. a biosensor, it is characterised in that: it contains the Aspergillus flavus acting on versicolorin described in claim 1 Toxin oxidase.
Biosensor the most according to claim 7 is for detecting the variegated aspergillosis in grain, food and raw material thereof, feedstuff The purposes of the content of element.
CN201410370164.3A 2014-07-30 2014-07-30 Act on the aflatoxin oxidase of versicolorin Active CN104130984B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410370164.3A CN104130984B (en) 2014-07-30 2014-07-30 Act on the aflatoxin oxidase of versicolorin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410370164.3A CN104130984B (en) 2014-07-30 2014-07-30 Act on the aflatoxin oxidase of versicolorin

Publications (2)

Publication Number Publication Date
CN104130984A CN104130984A (en) 2014-11-05
CN104130984B true CN104130984B (en) 2016-09-28

Family

ID=51803838

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410370164.3A Active CN104130984B (en) 2014-07-30 2014-07-30 Act on the aflatoxin oxidase of versicolorin

Country Status (1)

Country Link
CN (1) CN104130984B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104611305B (en) * 2014-12-30 2017-11-17 暨南大学 The Aflatoxin-detofizyme that trypsin-resistant improves
CN112760300B (en) * 2021-01-29 2022-08-30 潍坊康地恩生物科技有限公司 Aflatoxin degrading enzyme mutant and production strain thereof
CN117887681B (en) * 2024-03-13 2024-05-24 潍坊新希望六和饲料科技有限公司 Application of horseradish peroxidase in preparation of mildew-removed feed

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1113098C (en) * 1998-06-30 2003-07-02 广东药学院 Process for extracting detoxicating enzyme for aflatoxin B1
CN1294255C (en) * 2004-08-17 2007-01-10 广州科仁生物工程有限公司 Toxicide enzyme with aflatoxin activity conversion and gene for coding the enzyme

Also Published As

Publication number Publication date
CN104130984A (en) 2014-11-05

Similar Documents

Publication Publication Date Title
JP6322279B2 (en) Novel glucose oxidase mutant
CN101535476A (en) Modified flavine-adenine-dinucleotide-dependent glucose dehydrogenase
HILL et al. Purification of Escherichia coli acetohydroxyacid synthase isoenzyme II and reconstitution of active enzyme from its individual pure subunits
JP6526572B2 (en) Flavin-binding glucose dehydrogenase with improved thermal stability
CN104774813B (en) A kind of leucine dehydrogenase and its preparation method and application
CN110066777B (en) Endo-inulase and application thereof in production of fructo-oligosaccharide
CN104130984B (en) Act on the aflatoxin oxidase of versicolorin
CN108588061B (en) Low-temperature alkaline pectinase mutant with improved specific enzyme activity and thermal stability
CN101591664A (en) The gene of a kind of high antimer selective epoxidation thing lytic enzyme and coding thereof
JP7084867B2 (en) Flavin-bound glucose dehydrogenase variant
CN106282205A (en) A kind of high than L-GLOD gene multisite mutant alive and its preparation method and application
Linares et al. Tyramine biosynthesis in Enterococcus durans is transcriptionally regulated by the extracellular pH and tyrosine concentration
CN107446902B (en) Zearalenone toxin degrading enzyme ZENdease-N2 and encoding gene and application thereof
CN107217046A (en) A kind of zearalenone toxin degradation enzyme ZENdease N1 and its encoding gene and application
CN107858337A (en) A kind of heat-resisting mutant lipase and preparation method and application
JP6460513B2 (en) Protein with flavin adenine dinucleotide-dependent glucose dehydrogenase activity
WO2003091430A1 (en) GLUCOSE DEHYDROGENASE β-SUBUNIT AND DNA ENCODING THE SAME
CN107502602A (en) The preparation and its application for the hot rod bacterium xylanase mutant that two heat resistances improve
JP6455430B2 (en) Xanthine oxidase gene and the amino acid sequence encoding it
CN102864132A (en) Xylosidase with high heat resistance as well as coding gene and applications of xylosidase
CN105734027B (en) A kind of xanthine dehydrogenase and its encoding gene and application
US10865405B2 (en) Maltooligosyl trehalose synthase mutant with improved thermal stability
CN103290039B (en) Alpha-amylase derived from animal feces metagenome and gene of the alpha-amylase
CN106929491B (en) (S)-carbonyl reductase heteromer and its application in the more benzene ring compounds of catalysis
CN110438055A (en) A kind of whole-cell catalyst containing phenylpyruvate decarboxylase mutant and the application in production benzyl carbinol

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20210813

Address after: 529339 Building 1, No. 5, Huanxin Road, biaohai Industrial Zone, Shatang Town, Kaiping City, Jiangmen City, Guangdong Province

Patentee after: Guangdong Fang can animal health care Co.,Ltd.

Address before: 510632 No. 601, Whampoa Avenue, Tianhe District, Guangdong, Guangzhou

Patentee before: Jinan University

TR01 Transfer of patent right